Patent Opposition Database

Join our community to challenge unmerited drug patents

  1. Home
  2. Drugs
  3. Crispr/Cas9

CRISPR/Cas9

Download data Subscribe to updates
Abbreviation
CRISPR/Cas9
Disease(s)
Various
Patent oppositions filed in
Colombia

Clustered regularly interspaced short palindromic repeats (CRISPR, pronounced crisper) are segments of prokaryotic DNA containing short, repetitive base sequences. A simple version of the CRISPR/Cas system, CRISPR/Cas9, has been modified to edit genomes. CRISPR/Cas genome editing techniques have many potential applications, including medicine.

Source: https://en.wikipedia.org/wiki/CRISPR

This drug is missing the following documents, can you help us by contributing something?

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Colombia26-06-2015Oscar Lizarazo (Plebio Research Group)Pre-GrantUnder ExaminationOtherWO/2013/176772 View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top